LATS1 and breast cancer: Silencing of LATS1 in MCF7 cells resulted in increased expression of genes associated with resistance to hormone therapy, particularly tamoxifen (Fig 7H), supporting a role for LATS1 in maintaining estrogen dependence of luminal breast cancer cells.